Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001199835-20-000091
Filing Date
2020-03-26
Accepted
2020-03-25 18:53:05
Documents
42
Period of Report
2019-03-31

Document Format Files

Seq Description Document Type Size
1 GENETHERA, INC.03/31/2019 10-Q form-10q.htm 10-Q 302065
2 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO SECTION 302 OF THE SARBAN ex31-1.htm EX-31.1 18283
3 CERTIFICATE OF THE CHIEF FINANCIAL OFFICER PURSUANT TO SECTION 302 OF THE SARBAN ex31-2.htm EX-31.2 18123
4 CERTIFICATE OF THE CHIEF EXECUTIVE OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, A ex32-1.htm EX-32.1 3316
5 CERTIFICATE OF THE CHIEF FINANCIAL OFFICER PURSUANT TO 18 U.S.C. SECTION 1350, A ex32-2.htm EX-32.2 3333
6 GRAPHIC gt001_v1.jpg GRAPHIC 3190
  Complete submission text file 0001199835-20-000091.txt   1560612

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE gnth-20190331.xml EX-101.INS 185923
8 XBRL SCHEMA FILE gnth-20190331.xsd EX-101.SCH 18689
9 XBRL CALCULATION FILE gnth-20190331_cal.xml EX-101.CAL 31541
10 XBRL DEFINITION FILE gnth-20190331_def.xml EX-101.DEF 58717
11 XBRL LABEL FILE gnth-20190331_lab.xml EX-101.LAB 137696
12 XBRL PRESENTATION FILE gnth-20190331_pre.xml EX-101.PRE 114226
Mailing Address 6860 BROADWAY UNIT B DENVER CO 80221
Business Address 6860 BROADWAY UNIT B DENVER CO 80221 3039550190
GENETHERA INC (Filer) CIK: 0001017110 (see all company filings)

EIN.: 650622463 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-27237 | Film No.: 20743515
SIC: 2836 Biological Products, (No Diagnostic Substances)